Legal Representation
Attorney
Mary Grieco Lee
USPTO Deadlines
Next Deadline
1828 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-29)
Due Date
October 29, 2030
Grace Period Ends
April 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 29, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 29, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 13, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 13, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 8, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 8, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 8, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 28, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 28, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 28, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 26, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 22, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 27, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic
foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and
autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune
diseases; Vaccines; medicated serums for the treatment of cancer and autoimmune diseases; Chemical reagents for medical use;
Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators;
Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the
treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
Classification
International Classes
005